149 related articles for article (PubMed ID: 27143880)
1. Potential antitumor activity of novel DODAC/PHO-S liposomes.
Luna AC; Saraiva GK; Filho OM; Chierice GO; Neto SC; Cuccovia IM; Maria DA
Int J Nanomedicine; 2016; 11():1577-91. PubMed ID: 27143880
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative and proapoptotic effects of DODAC/synthetic phosphoethanolamine on hepatocellular carcinoma cells.
Luna ACL; Saraiva GKV; Chierice GO; Hesse H; Maria DA
BMC Pharmacol Toxicol; 2018 Jul; 19(1):44. PubMed ID: 29996919
[TBL] [Abstract][Full Text] [Related]
3. Modulation of pro-apoptotic effects and mitochondrial potential on B16F10 cells by DODAC/PHO-S liposomes.
Luna ACL; Santos Filho JRA; Hesse H; Neto SC; Chierice GO; Maria DA
BMC Res Notes; 2018 Feb; 11(1):126. PubMed ID: 29444697
[TBL] [Abstract][Full Text] [Related]
4. Synthetic phosphoethanolamine a precursor of membrane phospholipids reduce tumor growth in mice bearing melanoma B16-F10 and in vitro induce apoptosis and arrest in G2/M phase.
Ferreira AK; Meneguelo R; Marques FL; Radin A; Filho OM; Neto SC; Chierice GO; Maria DA
Biomed Pharmacother; 2012 Oct; 66(7):541-8. PubMed ID: 22902646
[TBL] [Abstract][Full Text] [Related]
5. Anti-angiogenic and anti-metastatic activity of synthetic phosphoethanolamine.
Ferreira AK; Freitas VM; Levy D; Ruiz JL; Bydlowski SP; Rici RE; Filho OM; Chierice GO; Maria DA
PLoS One; 2013; 8(3):e57937. PubMed ID: 23516420
[TBL] [Abstract][Full Text] [Related]
6. Synthetic phosphoethanolamine induces cell cycle arrest and apoptosis in human breast cancer MCF-7 cells through the mitochondrial pathway.
Ferreira AK; Meneguelo R; Pereira A; Filho OM; Chierice GO; Maria DA
Biomed Pharmacother; 2013 Jul; 67(6):481-7. PubMed ID: 23773853
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of large dioctadecyldimethylammonium chloride liposomes and comparison with small sonicated vesicles.
Ribeiro AM; Chaimovich H
Biochim Biophys Acta; 1983 Aug; 733(1):172-9. PubMed ID: 6882751
[TBL] [Abstract][Full Text] [Related]
8. Dioctadecyldimethylammonium:monoolein nanocarriers for efficient in vitro gene silencing.
Oliveira AC; Martens TF; Raemdonck K; Adati RD; Feitosa E; Botelho C; Gomes AC; Braeckmans K; Real Oliveira ME
ACS Appl Mater Interfaces; 2014 May; 6(9):6977-89. PubMed ID: 24712543
[TBL] [Abstract][Full Text] [Related]
9. New potential antiproliferative monophosphoester 2-aminoethyl dihydrogen phosphate in K-562 and K-562 MDR
Conceição TO; Cabral L; Laveli-Silva MG; Pacheco JC; Alves MG; Rabelo DC; Laiso R; Maria DA
Biomed Pharmacother; 2021 Oct; 142():112054. PubMed ID: 34463267
[TBL] [Abstract][Full Text] [Related]
10. Extruded vesicles of dioctadecyldimethylammonium bromide and chloride investigated by light scattering and cryogenic transmission electron microscopy.
Lopes A; Edwards K; Feitosa E
J Colloid Interface Sci; 2008 Jun; 322(2):582-8. PubMed ID: 18402974
[TBL] [Abstract][Full Text] [Related]
11. Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study.
Ferreira AK; Meneguelo R; Pereira A; Mendonça Filho O; Chierice GO; Maria DA
Anticancer Res; 2012 Jan; 32(1):95-104. PubMed ID: 22213293
[TBL] [Abstract][Full Text] [Related]
12. The role of counterion on the thermotropic phase behavior of DODAB and DODAC vesicles.
Feitosa E; Alves FR
Chem Phys Lipids; 2008 Nov; 156(1-2):13-6. PubMed ID: 18771662
[TBL] [Abstract][Full Text] [Related]
13. Cationic Liposomes with Different Lipid Ratios: Antibacterial Activity, Antibacterial Mechanism, and Cytotoxicity Evaluations.
Lu P; Zhang X; Li F; Xu KF; Li YH; Liu X; Yang J; Zhu B; Wu FG
Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36559007
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
[TBL] [Abstract][Full Text] [Related]
15. A Lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells.
Lin YL; Liu YK; Tsai NM; Hsieh JH; Chen CH; Lin CM; Liao KW
Nanomedicine; 2012 Apr; 8(3):318-27. PubMed ID: 21704596
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Antitumor Activity of Quaternary Ammonium Surfactants.
Hyla K; Jama D; Grzywacz A; Janek T
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139066
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies.
Zhang YF; Wang JC; Bian DY; Zhang X; Zhang Q
Eur J Pharm Biopharm; 2010 Mar; 74(3):467-73. PubMed ID: 20064608
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer mediated by fusion protein hemagglutinin reconstituted in cationic lipid vesicles.
Schoen P; Chonn A; Cullis PR; Wilschut J; Scherrer P
Gene Ther; 1999 May; 6(5):823-32. PubMed ID: 10505107
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation.
Ravar F; Saadat E; Gholami M; Dehghankelishadi P; Mahdavi M; Azami S; Dorkoosh FA
J Control Release; 2016 May; 229():10-22. PubMed ID: 26968799
[TBL] [Abstract][Full Text] [Related]
20. Characterization of lipid DNA interactions. I. Destabilization of bound lipids and DNA dissociation.
Harvie P; Wong FM; Bally MB
Biophys J; 1998 Aug; 75(2):1040-51. PubMed ID: 9675205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
